Januvia Gains Indication For Initial Diabetes Treatment With Metformin
This article was originally published in The Pink Sheet Daily
Executive Summary
Labeling for Merck’s DPP-4 inhibitor is also updated to include additional new regimens, as well as warning on hypersensitivity reactions.